Patient-specific factors predictive of warfarin dosage requirements

被引:87
作者
Absher, RK
Moore, ME
Parker, MH
机构
[1] Wesley Long Community Hosp, Greensboro, NC 27403 USA
[2] LeBauer HealthCare, Cardiovasc Risk Reduct Clin, Greensboro, NC USA
关键词
predictive factors; warfarin dosage;
D O I
10.1345/aph.1C025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To identify patient-specific factors predictive of maintenance warfarin dosage requirements >5 mg/d. METHODS: One hundred forty-six adults taking warfarin were identified from a community hospital and an outpatient anticoagulation clinic. Patient demographics and data on warfarin doses, laboratory results, and medication use were obtained by abstracting patient records. Estimates of vitamin K intake were obtained using a questionnaire and structured interview. Multiple logistic regression was used to identify patient characteristics independently predictive of warfarin maintenance requirements >5 mg/d. An assessment tool for estimating an individual patient's likelihood of requiring warfarin maintenance doses >5 mg/d was derived from the logistic regression model and was assessed in both the study cohort and a separate historical validation cohort of 125 patients. RESULTS: Five factors were independently associated with warfarin requirements >5 mg/d: age <55 years, male gender, African American ethnicity, vitamin K intake >400 mug/d, and body weight greater than or equal to91 kg. The assessment tool derived from these factors correctly classified semiquantitative warfarin requirements as non-high-dose in 84 of 93 study cohort patients and 71 of 78 validation cohort patients, and correctly classified requirements as high-dose in 10 of 13 study cohort patients and 11 of 15 validation cohort patients. CONCLUSIONS: African American ethnicity is a newly identified predictor of warfarin requirements >5 mg/d and is independent of dietary vitamin K intake. An assessment tool incorporating this and other predictors can estimate a patient's likelihood of requiring such dosages.
引用
收藏
页码:1512 / 1517
页数:6
相关论文
共 24 条
  • [1] Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy
    Beckey, NP
    Korman, LB
    Parra, D
    [J]. PHARMACOTHERAPY, 1999, 19 (09): : 1075 - 1079
  • [2] Racial background is a determinant of average warfarin dose required to maintain the INR between 2•0 and 3•0
    Blann, A
    Hewitt, J
    Siddiqui, F
    Bareford, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) : 207 - 209
  • [3] Food sources and dietary intakes of vitamin K-1 (phylloquinone) in the American diet: Data from the FDA Total Diet Study
    Booth, SL
    Pennington, JAT
    Sadowski, JA
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1996, 96 (02) : 149 - 154
  • [4] Dietary intake and adequacy of vitamin K
    Booth, SL
    Suttie, JW
    [J]. JOURNAL OF NUTRITION, 1998, 128 (05) : 785 - 788
  • [5] A randomized trial comparing 5-mg and 10-mg warfarin loading doses
    Crowther, MA
    Ginsberg, JB
    Kearon, C
    Harrison, L
    Johnson, J
    Massicotte, P
    Hirsh, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (01) : 46 - 48
  • [6] The association of vitamin K status with warfarin sensitivity at the onset of treatment
    Cushman, M
    Booth, SL
    Possidente, CJ
    Davidson, KW
    Sadowski, JA
    Bovill, EG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 572 - 577
  • [7] Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans
    Dickmann, LJ
    Rettie, AE
    Kneller, MB
    Kim, RB
    Wood, AJJ
    Stein, CM
    Wilkinson, GR
    Schwarz, UI
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (02) : 382 - 387
  • [8] AGE AND WEIGHT AS DETERMINANTS OF WARFARIN REQUIREMENTS
    DOBRZANSKI, S
    DUNCAN, SE
    HARKISS, A
    WARDLAW, A
    [J]. JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1983, 8 (01): : 75 - 77
  • [9] AGING AND THE ANTICOAGULANT RESPONSE TO WARFARIN THERAPY
    GURWITZ, JH
    AVORN, J
    ROSSDEGNAN, D
    CHOODNOVSKIY, I
    ANSELL, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (11) : 901 - 904
  • [10] HANSTON PD, 2001, FACTS COMPARISONS